These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MMR vaccine coverage at 24 months stabilises in the UK. Commun Dis Rep CDR Wkly; 1999 Mar 26; 9(13):113, 116. PubMed ID: 10230112 [No Abstract] [Full Text] [Related]
3. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines. Heath TC, Burgess MA, O'Brien ED. Commun Dis Intell; 1998 Aug 06; 22(8):159. PubMed ID: 9735551 [No Abstract] [Full Text] [Related]
4. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region]. Salvadori P. Ann Ig; 1998 Aug 06; 10(1):19-24. PubMed ID: 9616974 [No Abstract] [Full Text] [Related]
12. From the Centers for Disease Control and Prevention. Measles--United States, 1996, and the interruption of indigenous transmission. JAMA; 1997 May 07; 277(17):1345-6. PubMed ID: 9134928 [No Abstract] [Full Text] [Related]
15. [Issues related to rubella, measles and epidemic parotiditis in the Russian Federation]. Zverev VV, Iuminova NV. Vopr Virusol; 2004 May 07; 49(3):8-11. PubMed ID: 15188648 [Abstract] [Full Text] [Related]
19. Two doses of MMR vaccine--sufficient to eradicate measles, mumps and rubella? Fahlgren K. Scand J Soc Med; 1988 May 07; 16(3):129-35. PubMed ID: 3057621 [Abstract] [Full Text] [Related]
20. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population]. Janaszek-Seydlitz W, Bucholc B, Wysokińska T, Górska P, Gniadek G. Przegl Epidemiol; 2003 May 07; 57(2):281-8. PubMed ID: 12910596 [Abstract] [Full Text] [Related] Page: [Next] [New Search]